State Street Corporation 13D and 13G filings for BridgeBio Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:16 am Sale |
2023-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
STATE STREET CORP STT |
5,086,899 2.920% |
-3,758,044 (-42.49%) |
Filing |
| 2023-02-08 10:30 am Purchase |
2022-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
STATE STREET CORP STT |
8,844,943 5.920% |
8,844,943 (New Position) |
Filing |